Cargando…
Combining random mutagenesis, structure-guided design and next-generation sequencing to mitigate polyreactivity of an anti-IL-21R antibody
Despite substantial technological advances in antibody library and display platform development, the number of approved biotherapeutics from displayed libraries remains limited. In vivo, 20–50% of peripheral B cells undergo a process of receptor editing, which modifies the variable and junctional re...
Autores principales: | Campbell, Sharon M., DeBartolo, Joseph, Apgar, James R., Mosyak, Lydia, McManus, Virginie, Beyer, Sonia, Bennett, Eric M., Lambert, Matthew, Cunningham, Orla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889167/ https://www.ncbi.nlm.nih.gov/pubmed/33557673 http://dx.doi.org/10.1080/19420862.2021.1883239 |
Ejemplares similares
-
Polyreactivity and polyspecificity in therapeutic antibody development: risk factors for failure in preclinical and clinical development campaigns
por: Cunningham, Orla, et al.
Publicado: (2021) -
Therapeutic Potential of HLA-I Polyreactive mAbs Mimicking the HLA-I Polyreactivity and Immunoregulatory Functions of IVIg
por: Ravindranath, Mepur H., et al.
Publicado: (2021) -
An in silico method to assess antibody fragment polyreactivity
por: Harvey, Edward P., et al.
Publicado: (2022) -
Aromatic Guanylhydrazones for the Control of Heme-Induced
Antibody Polyreactivity
por: Božinović, Nina, et al.
Publicado: (2019) -
Crystal structure of ultra-humanized anti-pTau Fab reveals how germline substitutions humanize CDRs without loss of binding’
por: Brinth, Alette R., et al.
Publicado: (2022)